PDSB earnings: a negative outcome, -15.9%

On May 11, 2022, PDS Biotechnology Corp reached its earnings. The result was a negative outcome, and the stock moved -15.9% in the window around the event. It had already run -7.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.